Business
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Decision Diagnostics Corp. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Decision Diagnostics Corp. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm.
About this update from Decision Diagnostics Corp
[{"type":"text","content":"\nThe Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Decision Diagnostics Corp. (“Decision Diagnostics” or “the Company”) (OTC: DECN) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.\n\nInvestors who purchased the Company's securities between March 3, 2020 and December 17, 2020, inclusive (the ''Class Period''), are encouraged to contact the firm before March 16, 2021.\n\nIf you are a shareholder who suffered a loss, click here to participate.\n\nWe also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at [email protected].\n\nThe class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.\n\nAccording to the Complaint, the Company made false and misleading statements to the market. Decision Diagnostics failed to develop a viable COVID-19 test in any form, let alone a test that could detect the virus in less than one minute. The Company was not capable of meeting the FDA's EUA testing requirements for its purported COVID-19 test. Despite this inability to meet FDA requirements, the Company touted an unrealistic time to market for its tests. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Decision Diagnostics, investors suffered damages.\n\nJoin the case to recover your losses.\n\nThe Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.\n\nThis press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210116005023/en/","length":4248,"tagName":"div"}]